Risk of reinfection after two- or multiple-stage knee revision surgery using superficial vancomycin coating and conventional spacers.
Anti-Bacterial Agents
/ therapeutic use
Arthritis, Infectious
/ drug therapy
Arthroplasty, Replacement, Knee
/ adverse effects
Humans
Knee Joint
/ surgery
Knee Prosthesis
/ adverse effects
Prosthesis-Related Infections
/ drug therapy
Reinfection
Reoperation
Retrospective Studies
Treatment Outcome
Vancomycin
/ therapeutic use
coating
failed knee arthroplasty
spacer
two-stage revision
vancomycin
Journal
Journal of orthopaedic research : official publication of the Orthopaedic Research Society
ISSN: 1554-527X
Titre abrégé: J Orthop Res
Pays: United States
ID NLM: 8404726
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
revised:
06
10
2020
received:
23
03
2020
accepted:
21
10
2020
pubmed:
30
10
2020
medline:
14
4
2022
entrez:
29
10
2020
Statut:
ppublish
Résumé
This study investigates the effect of superficial vancomycin coating (SVC) in two- or more-stage exchange procedures of prosthetic knee joint infections. We hypothesized that spacer treatment with SVC result in lower reinfection rates than conventional spacers after prosthetic reimplantation. Our secondary aim was to determine the demographic and treatment factors associated with reinfection rates. This retrospective cohort study compromised 96 cases with prosthetic knee infections. Twenty-four cases were treated with a temporary SVC spacer and 72 cases with conventional spacers. Prosthetic reinfection occurred after a median observation period of 1.7 ± 4.0 years in 24 cases (25%). The prevalence of having a reinfection was not significantly different between the two treatment groups (13% [3 cases] in the SVC group vs. 29% [21 cases] in the conventional spacer group [p = .104]). In seven cases (7.3%), two in the SVC group (8.3%) and five (6.9%) in the conventional spacer group (p ≥ .999), histological, respectively microbiological evaluations from the intraoperative specimens revealed persistent infection at the second stage. Nevertheless, in all seven cases no significant higher risk of periprosthetic reinfection was observed during follow-up (p = .750). Our secondary investigation of cofactors revealed that spacers additionally stabilized by nails were significantly associated with a 3.9-fold higher hazard ratio of sustaining a reinfection of revision prosthesis (p = .005).
Identifiants
pubmed: 33118642
doi: 10.1002/jor.24892
pmc: PMC8451795
doi:
Substances chimiques
Anti-Bacterial Agents
0
Vancomycin
6Q205EH1VU
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1700-1709Informations de copyright
© 2020 The Authors. Journal of Orthopaedic Research® published by Wiley Periodicals LLC on behalf of Orthopaedic Research Society.
Références
J Antimicrob Chemother. 1990 Apr;25(4):679-87
pubmed: 2351627
J Bone Joint Surg Br. 1986 Mar;68(2):289-91
pubmed: 3958017
N Engl J Med. 2004 Oct 14;351(16):1645-54
pubmed: 15483283
Knee. 2012 Jan;19(1):24-7
pubmed: 21211978
Clin Infect Dis. 2013 Jul;57(2):328-9
pubmed: 23537904
J Bone Joint Surg Br. 2012 Feb;94(2):249-53
pubmed: 22323695
J Clin Med. 2020 Sep 08;9(9):
pubmed: 32911842
Pharmacotherapy. 2009 Nov;29(11):1275-9
pubmed: 19873687
J Orthop Res. 2014 Jan;32 Suppl 1:S141-6
pubmed: 24464888
Clin Orthop Relat Res. 2012 Sep;470(9):2599-604
pubmed: 22476896
J Arthroplasty. 1996 Dec;11(8):939-44
pubmed: 8986572
Orthopedics. 2016 May 1;39(3):e553-7
pubmed: 27045481
Acta Orthop. 2012 Jun;83(3):311-3
pubmed: 22640179
World J Orthop. 2014 Nov 18;5(5):667-76
pubmed: 25405096
Knee Surg Relat Res. 2015 Jun;27(2):82-9
pubmed: 26060606
Antimicrob Agents Chemother. 2006 Jan;50(1):332-5
pubmed: 16377705
SICOT J. 2017;3:2
pubmed: 28074774
J Orthop Res. 2006 Aug;24(8):1615-21
pubmed: 16788986
Clin Orthop Relat Res. 2010 Aug;468(8):2060-6
pubmed: 20300903
Acta Orthop Belg. 2013 Aug;79(4):422-6
pubmed: 24205773
J Bone Joint Surg Am. 1976 Apr;58(3):358-64
pubmed: 770477
Knee Surg Sports Traumatol Arthrosc. 2016 Oct;24(10):3106-3114
pubmed: 26392344
J Arthroplasty. 1998 Jan;13(1):22-8
pubmed: 9493534
J Bone Joint Surg Am. 2015 Sep 16;97(18):1495-502
pubmed: 26378265
J Orthop Res. 2021 Aug;39(8):1700-1709
pubmed: 33118642
J Bone Jt Infect. 2017 Nov 13;2(4):208-212
pubmed: 29188172
Int Orthop. 2012 Jan;36(1):65-71
pubmed: 21553042
Curr Rev Musculoskelet Med. 2015 Dec;8(4):373-82
pubmed: 26395472
Acta Orthop. 2009 Apr;80(2):193-7
pubmed: 19404802
J Arthroplasty. 2014 Mar;29(3):553-7.e1
pubmed: 24011676
J Bone Joint Surg Am. 2006 Nov;88(11):2487-500
pubmed: 17079409
Clin Orthop Surg. 2011 Sep;3(3):245-8
pubmed: 21909473
Clin Orthop Relat Res. 2011 Nov;469(11):3049-54
pubmed: 21866421
Kidney Int. 2010 May;77(9):760-4
pubmed: 20182415
Clin Orthop Relat Res. 2018 Oct;476(10):1986-1992
pubmed: 30794242
Int J Artif Organs. 2012 Oct;35(10):923-34
pubmed: 23138706
Knee Surg Sports Traumatol Arthrosc. 2016 Jan;24(1):84-8
pubmed: 25246173
J Bone Joint Surg Am. 2018 May 2;100(9):742-750
pubmed: 29715222
J Arthroplasty. 2014 Jul;29(7):1449-56
pubmed: 24636904
J Arthroplasty. 2020 Sep;35(9):2601-2606.e1
pubmed: 32451282
J Arthroplasty. 2017 May;32(5):1618-1624
pubmed: 28111125
Orthop Clin North Am. 2005 Jan;36(1):17-28, v
pubmed: 15542119
J Arthroplasty. 1998 Apr;13(3):331-8
pubmed: 9590645
Iowa Orthop J. 2012;32:104-15
pubmed: 23576930
Clin Orthop Relat Res. 2014 Jul;472(7):2208-14
pubmed: 24658903